News Focus
News Focus
Followers 616
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: BRIG_88 post# 81347

Tuesday, 02/18/2014 1:11:54 PM

Tuesday, February 18, 2014 1:11:54 PM

Post# of 146478
brig... I have a funny hobby that turns out to be related to this topic. I fold proteins as a volunteer for a major university. I've thrown the concept out to a few of my fellow folders, the ones that are more deeper into the biology and chemistry than I am. They can see it work in theory. But, what percentage of the virus is attached to nanoviricides vs host cell? The pre clinicals look good and we're all quite hopeful it ends up working in humans as it does in animals.

And, if the company has a source for the various receptor ligands needed for different diseases this would be amazing.

Can anyone thats been here awhile expand on this issue?

Trials should go quickly with the flu once started. My understanding is the next step we are waiting for is tox studies.

I have to go and hope to see someone expand on this issue sometime later once I'm back.

Btw, the CEO communication style doesn't bother me. I much prefer them too open over too silent.





In Reply to 'BRIG_88'
This Flucide…i'm no doctor or scientist but my bullshit radar went up immediately when i see a name put to something early stage like this….currently flu vaccines are a one off inoculation for a specific strain of flu virus….i don't see Flucide ever becoming a panacea for all strains of flu viruses…i just don't see it….i also find it disturbing the CEO has time to email individual shareholders and discuss message boards?….has anyone gotten communication from him in this regard?…if so this is very bush league imo.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News